Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
RESEARCH INFRASTRUCTURES
Main Policy Aspects and Challenges
INFRAFRONTIER stakeholder event, Athens 14-16/11/2017
Maria Christoula (PhD)
2
The R&D landscape and main policy challenges
Process for a national roadmap and a funding plan for Research Infrastructures
Elements of the multiannual funding plan for Research Infrastructures
Agenda
3
Aspects of the R&D landscape
R & D investment Up to 0,99% of GDP in 2016 – Increase of the research institutions budget Public investment raised ~30% in 2016 1000 new posts in universities, 100 new posts in research institutes for 2017-
2018
HFRI – Hellenic Foundation of Research & Innovation Supporting “blue sky” research, 240 m€ / 3 years (180m € - ΕΙΒ, 60m€ - National Funds), > 4000 PhD & post-doc grants Horizon 2020 competitive performance of Greek research groups (from Interim report) Structural Funds 2014-2020 Mainly for applied research and scientific innovation ~1.2b€ and 9000 job positions for young scientists
Highly competitive human research potential…
13th place
50.052.240,88
51.212.951,63
66.458.307,29
73.125.620,68
79.550.113,11
85.509.207,52
90.001.962,81
103.312.178,90
150.888.819,98
163.324.808,10
171.211.092,56
232.848.669,23
416.873.943,93
434.293.977,99
451.891.912,48
457.609.277,01
549.631.648,11
563.084.336,33
566.410.915,43
630.440.520,76
709.964.811,53
889.906.219,82
1.236.888.926,57
1.981.284.109,27
2.101.877.606,09
2.309.008.624,25
2.688.836.804,38
3.897.904.109,43
4.291.703.657,36
0,00 500.000.000,00 1.000.000.000,00 1.500.000.000,00 2.000.000.000,00 2.500.000.000,00 3.000.000.000,00 3.500.000.000,00 4.000.000.000,00 4.500.000.000,00 5.000.000.000,00
RS
IS
LU
SK
EE
CY
RO
TR
SI
HU
CZ
PL
PT
IE
IL
NO
EL
CH
FI
DK
AT
SE
BE
NL
IT
ES
FR
UK
DE
EU Financial Contribution per Country Data: EC CORDIS, Reference date: 12/10/2017
Analysis by V. Gongolidis, General Secretariat for Research and Technology, Greece Only countries with EC contribution > 50 M€ shown
(based on EU financial contribution from Η2020)
Highly competitive presence - Research
Infrastructures Programme - H2020
0
20.000.000
40.000.000
60.000.000
80.000.000
100.000.000
120.000.000
140.000.000
160.000.000
180.000.000
200.000.000
UK DE FR IT NL ES SE EL CH FI BE NO DK AT PL IE
8th place
H
2
0
2
0
E
U
f
u
n
d
i
n
g
€
The Innovation Gap ….
Overall Greece is a moderate innovator despite the good
performance in academic scientific indicators
Role of RIs
RIs are key structural elements of the R&D ecosystem as
- enablers of innovation
- bonding elements within the knowledge triangle
Need for a coherent national plan for RIs
to support the decision making process and to optimize investments for RΙs
to support an evidence – based national strategy linked to EU priorities
Towards a national policy for RIs
Excellence
Critical Mass/ National – International Networking/
Governance – Access Policy
Impact/innovation Potential
Athens, Nov. 2017
8
Limited national funds, dependence on structural funds (ESIF)
International networking of Greek teams Strong presence to H2020 – RI program and to ESFRI
Compliance with RIS3 (Ex-ante conditionality for Research Infrastructures)
Landscape and Challenges Targets
Fragmentation of effort & Infrastructures
Selection Process for funding
• Bottom up approach - open calls for expressions of interest (GSRT)
• Peer review by international experts & thematic panels (GSRT)
• Strategic prioritization by a High Level Committee (GSRT)
• Multi-annual funding plan
• Call for updated proposals (ERDF MA)
• Eligibility check (ERDF MA)
• Funding from Structural Funds
Athens, Nov. 2017
9
10
Evaluation Criteria
I ON/OFF CRITERIA
A Compliance with the definition of research infrastructure
B Contribution to the RIS3 priority areas: a. Its main activities are fully aligned to product / process / organizational innovation of RIS3 priority
sectors b. The majority of the RI deliverables and services contribute to the RIS3 priority sectors
II RANKING CRITERIA
A. Scientific, technological potential and maturity of the RI (1-5)
B. Effective Networking, Synergies within the Knowledge Triangle and International Visibility (1-5)
C. Access Policy (1-5)
D. Governance and Sustainability of the RI (1-5)
E. Innovation Potential & Contribution to Private Sector Innovation (1-5)
F. Contribution to National and Regional Growth & Socioeconomic Benefits (1-5)
11
Multi- Annual Funding Plan for RIs 2014-20
28 RIs
Multiannual funding Plan for National Research Infrastructures, November 2016 ex-ante-1-2_Nov 2016 V.11 (1).pdf
28 distributed infrastructures (hubs all around Greece)
12
Elements of the multiannual funding plan for RIs
11
17
0 2 4 6 8 10 12 14 16 18
Not ESFRI related
ESFRI related
ESFRI relation of Research Infrastructures
13
4
1
2
6
8
3
3
1
Agrofood
Culture, Tourism & Creative Industries
Energy
Environment & Sustainable Development
Health & Pharmaceuticals
ICT
Materials & Construction
Transport & Logistics
Elements of the multiannual funding plan for RIs
Athens, Nov. 2017
Distribution of RIs per thematic priority
14
Elements of the multiannual funding plan for RIs
7,03
1
4,1
9,78
9,69
2,57
7,51
0,91
4,61
1,6
1,95
8,36
9,64
2,69
3,07
1,01
2,54
1,4
1,95
5,38
5,66
0,31
1,42
1,08
0 5 10 15 20 25 30
Agrofood
Culture, Tourism & Creative Industries
Energy
Environment & Sustainable Development
Health & Pharmaceuticals
ICT
Materials & Construction
Transport & Logistics
Agrofood
Culture,Tourism &CreativeIndustries
EnergyEnvironment &Sustainable
Development
Health &Pharmaceutica
lsICT
Materials &Construction
Transport &Logistics
2017 7,03 1 4,1 9,78 9,69 2,57 7,51 0,91
2018 4,61 1,6 1,95 8,36 9,64 2,69 3,07 1,01
2019 2,54 1,4 1,95 5,38 5,66 0,31 1,42 1,08
Distribution of RIs funding per thematic priority and year
Biosciences & Health RIs
No Acronym Title ESFRI relation funding plan
1 INFRAFRONTIER-GR /
Phenotypos
The Greek Research Infrastructure for Molecular and Behavioral
Phenotyping of biological model organisms for chronic degenerative
diseases
INFRAFRONTIER 1st batch
2 pMED-GR The Greek Research Infrastructure for Personalised Medicine
Towards more accurate and cost-effective health management for the
Greek citizen
- 1st batch
3
BioImaging-GR
A Greek Research Infrastructure for visualizing and monitoring
fundamental biological processes
EURO-BioImaging 1st batch
4 Openscreen-GR An Open-Access Research Infrastructure of Chemical Biology and
Target-Based
Screening Technologies for Human and Animal Health, Agriculture
and the Environment
OpenSCREEN 1st batch
5 ELIXIR-GR Managing and analyzing biological data ELIXIR 1st batch
6 INSPIRED The National Research Infrastructures on Integrated Structural
Biology, Drug Screening Efforts and Drug‐target functional
characterization
INSTRUCT 1st batch
7 EATRIS-GR Infrastructure for preclinical and early-phase clinical
development of drugs, therapeutics and biomedical devices
EATRIS 2nd batch
8 BBMRI -GR Strategic expansion of the Greek Biobanking Infrastructure BBMRI 2nd batch
16
Contents of the presentation More Info…
Detailed info on the multiannual funding plan
http://www.gsrt.gr/central.aspx?sId=128I510I1381I646I528387
m.christoula [at] gsrt.gr
Backup Slides 18
High Level Advisory Committee meeting on 21& 22 /3/2016
main findings 19
The Roadmap process followed by the GSRT, with a bottom up approach, peer review by experts of international standing and advisory input from prominent representatives of the Greek RD&I ecosystem was of exceptionally high standard, fully aligned with international good practices
R&D intensity is increasing as % of GDP, as well as in absolute numbers - especially BERD
2011 2012 2013 2014 2015 2016 (p)
BES 485,86 458,60 488,69 504,37 561,59 722,88
GOV 331,73 331,90 410,13 412,69 479,35 428,86
HES 559,53 534,30 548,60 553,20 643,77 566,55
PNP 14,04 12,80 18,25 18,48 19,11 14,80
TOTAL 1.391,16 1.337,60 1.465,67 1.488,74 1.703,82 1.733,09
Total R&D
intensity for
2016 (p)
reached
0,99% of GDP
0,23 0,24 0,27 0,28 0,32
BES; 0,41
0,16 0,17 0,23 0,23
0,27 GOV; 0,24
0,27 0,28 0,30 0,31 0,37
HES; 0,32
0,01 0,01 0,01 0,01 0,01 PNP; 0,01
0,67 0,70
0,81
0,84
0,97 Total Intensity; 0,99
0,00
0,20
0,40
0,60
0,80
1,00
1,20
2011 2012 2013 2014 2015 2016 (p)
%
R&D Expenditure by sector of performance (% of GDP), 2011-2016